Titan Pharmaceuticals
TTNP
#10362
Rank
ยฃ4.61 M
Marketcap
ยฃ3.47
Share price
-3.76%
Change (1 day)
13.43%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -ยฃ3.38

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ3.30. In 2023 the company made an earnings per share (EPS) of -ยฃ5.57 an increase over its 2022 EPS that were of -ยฃ11.43.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ3.38
2023-ยฃ5.57-51.22%
2022-ยฃ11.43-15.61%
2021-ยฃ13.54-81.37%
2020-ยฃ72.67-77.52%
2019-ยฃ323.32-56.32%
2018-ยฃ740.23-59.51%
2017-ยฃ1,828-371.81%
2016ยฃ672.66-144.35%
2015-ยฃ1,517300%
2014-ยฃ379.14-121.54%
2013ยฃ1,760-151.38%
2012-ยฃ3,426-11.54%
2011-ยฃ3,873188.89%
2010-ยฃ1,341-10%
2009-ยฃ1,489
2007-ยฃ6,107-2.38%
2006-ยฃ6,256-39.13%
2005-ยฃ10,277-16.87%
2004-ยฃ12,363-22.43%
2003-ยฃ15,9384.9%
2002-ยฃ15,19361.9%
2001-ยฃ9,384-13.7%
2000-ยฃ10,87365.01%
1999-ยฃ6,590-35.87%
1998-ยฃ10,276-1824.71%
1997ยฃ595.80-102.4%
1996-ยฃ24,875

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ8.38-353.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.54-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-ยฃ1.07-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ0.02257-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ0.19-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ2.54-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA